133 related articles for article (PubMed ID: 26418334)
1. Survival impact of the Australian National Bowel Cancer Screening Programme.
Ananda S; Wong H; Faragher I; Jones IT; Steele M; Kosmider S; Desai J; Tie J; Field K; Wong R; Tran B; Bae S; Gibbs P
Intern Med J; 2016 Feb; 46(2):166-71. PubMed ID: 26418334
[TBL] [Abstract][Full Text] [Related]
2. Initial impact of Australia's National Bowel Cancer Screening Program.
Ananda SS; McLaughlin SJ; Chen F; Hayes IP; Hunter AA; Skinner IJ; Steel MC; Jones IT; Hastie IA; Rieger NA; Shedda S; Compston DJ; Gibbs P
Med J Aust; 2009 Oct; 191(7):378-81. PubMed ID: 19807627
[TBL] [Abstract][Full Text] [Related]
3. Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study.
Lew JB; St John DJB; Xu XM; Greuter MJE; Caruana M; Cenin DR; He E; Saville M; Grogan P; Coupé VMH; Canfell K
Lancet Public Health; 2017 Jul; 2(7):e331-e340. PubMed ID: 29253458
[TBL] [Abstract][Full Text] [Related]
4. Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment.
Worthington J; Lew JB; Feletto E; Holden CA; Worthley DL; Miller C; Canfell K
PLoS One; 2020; 15(2):e0227899. PubMed ID: 32012174
[TBL] [Abstract][Full Text] [Related]
5. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
Todorov K; Wilson C; Sharplin G; Corsini N
Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
[TBL] [Abstract][Full Text] [Related]
6. Analysis of colorectal cancer outcomes for the Australian National Bowel Cancer Screening Program.
;
Asia Pac J Clin Oncol; 2016 Mar; 12(1):22-32. PubMed ID: 26803949
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with participation in colorectal cancer screening in Australia: Results from the 45 and Up Study cohort.
He E; Lew JB; Egger S; Banks E; Ward RL; Beral V; Canfell K
Prev Med; 2018 Jan; 106():185-193. PubMed ID: 29109015
[TBL] [Abstract][Full Text] [Related]
8. SMARTERscreen protocol: a three-arm cluster randomised controlled trial of patient SMS messaging in general practice to increase participation in the Australian National Bowel Cancer Screening Program.
McIntosh JG; Emery JD; Wood A; Chondros P; Goodwin BC; Trevena J; Wilson C; Chang S; Hocking J; Campbell T; Macrae F; Milley K; Lew JB; Nightingale C; Dixon I; Castelli M; Lee N; Innes L; Jolley T; Fletcher S; Buchanan L; Doncovio S; Broun K; Austin G; Jiang J; Jenkins MA
Trials; 2023 Nov; 24(1):723. PubMed ID: 37957680
[TBL] [Abstract][Full Text] [Related]
9. Shift to earlier stage at diagnosis as a consequence of the National Bowel Cancer Screening Program.
Cole SR; Tucker GR; Osborne JM; Byrne SE; Bampton PA; Fraser RJ; Young GP
Med J Aust; 2013 Apr; 198(6):327-30. PubMed ID: 23545032
[TBL] [Abstract][Full Text] [Related]
10. Preliminary analysis of the cost-effectiveness of the National Bowel Cancer Screening Program: demonstrating the potential value of comprehensive real world data.
Tran B; Keating CL; Ananda SS; Kosmider S; Jones I; Croxford M; Field KM; Carter RC; Gibbs P
Intern Med J; 2012 Jul; 42(7):794-800. PubMed ID: 21883782
[TBL] [Abstract][Full Text] [Related]
11. Optimising the expansion of the National Bowel Cancer Screening Program.
Cenin DR; St John DJ; Ledger MJ; Slevin T; Lansdorp-Vogelaar I
Med J Aust; 2014 Oct; 201(8):456-61. PubMed ID: 25332032
[TBL] [Abstract][Full Text] [Related]
12. The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program.
Wood A; Emery JD; Jenkins M; Chondros P; Campbell T; Wenkart E; O'Reilly C; Cowie T; Dixon I; Toner J; Khalajzadeh H; Gutierrez JM; Govan L; Buckle G; McIntosh JG
Trials; 2022 Jan; 23(1):31. PubMed ID: 35022080
[TBL] [Abstract][Full Text] [Related]
13. Trust, choice and obligation: a qualitative study of enablers of colorectal cancer screening in South Australia.
Ward PR; Coffey C; Meyer S
Sociol Health Illn; 2015 Sep; 37(7):988-1006. PubMed ID: 25912247
[TBL] [Abstract][Full Text] [Related]
14. Family history-based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios.
Dillon M; Flander L; Buchanan DD; Macrae FA; Emery JD; Winship IM; Boussioutas A; Giles GG; Hopper JL; Jenkins MA; Ait Ouakrim D
PLoS Med; 2018 Aug; 15(8):e1002630. PubMed ID: 30114221
[TBL] [Abstract][Full Text] [Related]
15. Impact of bowel cancer screening on the management of colorectal cancer.
Hwang MJ; Evans T; Lawrence G; Karandikar S
Colorectal Dis; 2014 Jun; 16(6):450-8. PubMed ID: 24617851
[TBL] [Abstract][Full Text] [Related]
16. History, development and future of cancer screening in Australia.
Olver IN; Roder D
Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765858
[TBL] [Abstract][Full Text] [Related]
17. Colonoscopies in Australia - how much does the National Bowel Cancer Screening Program contribute to colonoscopy use?
Worthington J; He E; Lew JB; St John J; Horn C; Grogan P; Canfell K; Feletto E
Public Health Res Pract; 2023 Mar; 33(1):. PubMed ID: 36477980
[TBL] [Abstract][Full Text] [Related]
18. Screen-detected colorectal cancers show improved cancer-specific survival when compared with cancers diagnosed via the 2-week suspected colorectal cancer referral guidelines.
Courtney ED; Chong D; Tighe R; Easterbrook JR; Stebbings WS; Hernon J
Colorectal Dis; 2013 Feb; 15(2):177-82. PubMed ID: 22709315
[TBL] [Abstract][Full Text] [Related]
19. Bowel cancer screening--a role for general practice.
Foreman L
Aust Fam Physician; 2009 Apr; 38(4):200-3. PubMed ID: 19350068
[TBL] [Abstract][Full Text] [Related]
20. The National Bowel Cancer Screening Program: time to achieve its potential to save lives.
Ee H; St John J
Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
